Evaluation of Availability, Prices, and Affordability of Selected Essential Medicines in Balochistan, Pakistan

• Main Authors: Murad Bibi (Author), Noman Ul Haq (Author), Abdul Kareem (Author), Habib Ullah (Author), Nizam Baloch (Author), Gulalai Rehman (Author), Aqeel Nasim (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.
• Notes: 1661-8564; 10.3389/ijph.2022.1604375
• Keywords: affordability; WHO; price; availability; essential medicine; Pakistan; Public aspects of medicine; RA1-1270
• Source: International Journal of Public Health, Vol 67 (2022)

Objectives: The study aimed to evaluate the availability, prices, and affordability of selected essential medicines in Balochistan, Pakistan.Methods: Cross-sectional research was conducted in several cities of Balochistan, Pakistan, using the World Health Organization/Health Action International methodology to assess the availability and cost of 50 originator brand (OB) and lowest priced generic (LPG) drugs. The medicine costs were compared to international reference prices (IRPs) to calculate the median price ratio. The daily wage of the lowest paid unskilled government employee was used to determine affordability.Results: The mean availability was low for OBs (9.8%) and fairly high (49.4%) for LPGs. The OBs and LPGs' mean availability in the private sector were fairly high, 51.8% and 42.6%, respectively. It was surprising to see that Balochistan's public sector has only 24.3% of the National Essential Medicine List when the medicines on this list are supposed to be adequately available.Conclusion: The standard treatment cost with OBs is steep, exceeding the minimum daily wage. Treatment with LPG medications seems affordable. Furthermore, essential LPG medicines are economical when used solely for medication therapy.